Moderna begins study of Covid-19 vaccine in adolescents
Pfizer is also studying its vaccine candidate in participants as young as 12
Moderna Inc said on Thursday it had dosed the first participant in a mid-to-late stage study testing its Covid-19 vaccine candidate in adolescents aged 12 to less than 18.
The study is being conducted in collaboration with the Biomedical Advanced Research and Development Authority (BARDA).
“Our goal is to generate data in the spring of 2021 that will support the use of mRNA-1273 in adolescents in advance of the 2021 school year,” said Chief Executive Officer Stéphane Bancel.
The news comes as the United States prepares to begin distributing the first doses of Covid-19 vaccines from both Moderna and rival Pfizer/BioNTech to adults, upon regulatory nod for emergency use.
A panel of outside advisers to the US Food and Drug Administration will meet on Thursday to discuss whether to recommend the use of Pfizer’s vaccine for people aged 16 and older. A similar meeting of advisers to the FDA is scheduled for Dec. 17 to discuss Moderna’s vaccine.
Rival Pfizer is also studying its vaccine candidate in participants as young as 12.
1735203131-0/Untitled-design-(7)1735203131-0-270x192.webp "asma al assad reportedly given 50 50 chance of survival as leukemia returns")
1735199120-0/Untitled-design-(100)1735199120-0-270x192.webp "haneda airport collision report blames human error for crash with japan coast guard aircraft")
1735195617-0/Untitled-design-(99)1735195617-0-270x192.webp "japan airlines operations resume after cyberattack disrupts flights")
1735025557-0/Untitled-(96)1735025557-0-270x192.webp "christopher nolan casts zendaya tom holland anne hathaway and more in adaptation of the odyssey")
COMMENTS
Comments are moderated and generally will be posted if they are on-topic and not abusive.
For more information, please see our Comments FAQ